Preface |
|
iii | |
|
Normal Hemopoiesis and Blood Cells |
|
|
1 | (40) |
|
Hemopoietic stem and progenitor cells |
|
|
1 | (1) |
|
|
2 | (1) |
|
Hemopoietic growth factors |
|
|
3 | (4) |
|
|
6 | (1) |
|
|
6 | (1) |
|
Lymbphokines and monokines |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
9 | (1) |
|
Tumor necrosis factor (α) and lymphotoxin (tumor necrosis factor β) |
|
|
9 | (1) |
|
Migration inhibition factor |
|
|
9 | (1) |
|
Membrane-growth factor interactions |
|
|
9 | (4) |
|
|
9 | (1) |
|
|
10 | (2) |
|
|
12 | (1) |
|
|
12 | (1) |
|
Oncogenes and tumor suppressor genes |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
14 | (1) |
|
|
14 | (6) |
|
|
17 | (1) |
|
Granulopoiesis and monocyte production |
|
|
18 | (1) |
|
Megakaryocyte and platelet production |
|
|
19 | (1) |
|
Lymphocytes and plasma cells |
|
|
19 | (1) |
|
Assessment of iron status |
|
|
20 | (1) |
|
Osteoblasts and osteoclasts |
|
|
20 | (1) |
|
|
20 | (1) |
|
|
20 | (4) |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
26 | (1) |
|
Mononuclear phagocytic system |
|
|
26 | (4) |
|
|
26 | (1) |
|
Reticuloendothelial system: phagocytes and dendritic cells |
|
|
26 | (4) |
|
|
30 | (9) |
|
|
30 | (1) |
|
|
31 | (3) |
|
|
34 | (1) |
|
Lymphocyte proliferation and differentiation |
|
|
35 | (2) |
|
Somatic hypermutation in normal B cells |
|
|
37 | (1) |
|
|
37 | (2) |
|
|
39 | (2) |
|
Hypochromic anemias and Iron Overload |
|
|
41 | (16) |
|
|
41 | (1) |
|
|
41 | (6) |
|
Blood and bone marrow appearances |
|
|
42 | (3) |
|
Causes of iron deficiency |
|
|
45 | (2) |
|
|
47 | (4) |
|
|
51 | (1) |
|
|
52 | (1) |
|
Differential diagnosis of hypochromic microcytic anemias |
|
|
52 | (1) |
|
|
52 | (2) |
|
Congenital erythropoietic porphyria |
|
|
52 | (2) |
|
Congenital erythropoietic protoporphyria |
|
|
54 | (1) |
|
Iron overload: primary (genetic) hemochromatosis |
|
|
54 | (2) |
|
Other causes of iron overload |
|
|
56 | (1) |
|
Hereditary hyperferritinemia with autosomal dominant congenital cataract syndrome |
|
|
56 | (1) |
|
|
57 | (14) |
|
|
59 | (6) |
|
Blood count and blood film appearances |
|
|
61 | (1) |
|
|
62 | (3) |
|
Causes of megaloblastic anemia |
|
|
65 | (5) |
|
|
65 | (2) |
|
|
67 | (1) |
|
Abnormalities of vitamin B12 or folate metabolism |
|
|
67 | (2) |
|
|
69 | (1) |
|
Treatment of megaloblastic anemia |
|
|
70 | (1) |
|
Causes of macrocytosis other than megaloblastic anemia |
|
|
70 | (1) |
|
|
71 | (14) |
|
Hereditary hemolytic anemia |
|
|
73 | (6) |
|
|
73 | (1) |
|
Red cell blood group antigens |
|
|
73 | (1) |
|
|
74 | (1) |
|
Hereditary elliptocytosis |
|
|
74 | (1) |
|
South-east Asian ovalocytosis (stomatocytic hereditary elliptocytosis) |
|
|
74 | (2) |
|
Other rare inherited defects of the red cell membrane |
|
|
76 | (1) |
|
Normal red cell metabolism |
|
|
77 | (1) |
|
Glucose 6-phosphate dehydrogenase deficiency |
|
|
77 | (1) |
|
Pyruvate kinase deficiency |
|
|
78 | (1) |
|
Pyrimidine 5-nucleotidase deficiency |
|
|
78 | (1) |
|
Acquired hemolytic anemia |
|
|
79 | (6) |
|
Autoimmune hemolytic anemias |
|
|
79 | (2) |
|
Drug-induced immune hemolytic anemia |
|
|
81 | (1) |
|
Isoimmune hemolytic anemia |
|
|
81 | (1) |
|
Red cell fragmentation syndromes |
|
|
81 | (1) |
|
Secondary hemolytic anemias |
|
|
82 | (1) |
|
Paroxysmal nocturnal hemoglobinuria |
|
|
82 | (2) |
|
|
84 | (1) |
|
Genetic Disorders of Hemoglobin |
|
|
85 | (22) |
|
|
85 | (15) |
|
|
87 | (7) |
|
|
94 | (2) |
|
|
96 | (1) |
|
β-Thalassemia with a dominant phenotype |
|
|
96 | (1) |
|
|
97 | (1) |
|
|
98 | (1) |
|
X-Linked α-thalassemia and mental retardation syndrome |
|
|
99 | (1) |
|
The structural hemoglobin variants |
|
|
100 | (7) |
|
|
100 | (5) |
|
Other structural hemoglobin defects |
|
|
105 | (1) |
|
|
105 | (2) |
|
Aplastic, Dyserythropoietic and Secondary Anemias |
|
|
107 | (10) |
|
|
107 | (4) |
|
Congenital aplastic anemia |
|
|
107 | (1) |
|
|
108 | (2) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
Congenital dyserythropoietic anemias |
|
|
112 | (2) |
|
|
114 | (3) |
|
Benign Disorders of Leukocytes |
|
|
117 | (22) |
|
Hereditary variation in white cell morphology |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
Alder's (Alder--Reilly) anomaly |
|
|
118 | (1) |
|
Mucopolysaccharidoses VI and VII |
|
|
118 | (1) |
|
Other cause of lymphocyte vacuolation |
|
|
118 | (1) |
|
Disorders of phagocytic function |
|
|
118 | (1) |
|
|
118 | (2) |
|
Neutrophil leucocytosis (neutrophilia) |
|
|
118 | (2) |
|
Eosinophil leucocytosis (eosinophilia) |
|
|
120 | (1) |
|
Monocytosis and basophil leucocytosis |
|
|
120 | (1) |
|
|
120 | (1) |
|
Leucoerythroblastic reaction |
|
|
121 | (1) |
|
|
121 | (3) |
|
|
122 | (1) |
|
Shwachman-Diamond syndrome |
|
|
122 | (1) |
|
Clinical and bone marrow findings |
|
|
122 | (1) |
|
|
123 | (1) |
|
Histiocytic proliferations |
|
|
124 | (2) |
|
Lengerhan cell histiocytosis |
|
|
124 | (1) |
|
Hemophagocytic lymphohistiocytosis |
|
|
125 | (1) |
|
Sinus histiocytosis with massive lymphadenopathy |
|
|
126 | (1) |
|
|
126 | (5) |
|
|
126 | (4) |
|
|
130 | (1) |
|
Primary immunodeficiency disorders |
|
|
131 | (2) |
|
Acquired immune deficiency syndrome |
|
|
133 | (5) |
|
Autoimmune lymphoproliferative syndrome |
|
|
138 | (1) |
|
|
139 | (28) |
|
|
140 | (5) |
|
Microscopical appearances |
|
|
145 | (7) |
|
|
145 | (5) |
|
Acute lymphoblastic leukemia |
|
|
150 | (2) |
|
|
152 | (2) |
|
|
154 | (4) |
|
|
158 | (1) |
|
Congenital acute leukemia |
|
|
158 | (1) |
|
Acute leukemia and Down syndrome |
|
|
158 | (1) |
|
|
158 | (4) |
|
|
162 | (2) |
|
|
164 | (2) |
|
|
164 | (1) |
|
Acute lymphoblastic leukemia |
|
|
164 | (2) |
|
|
166 | (1) |
|
Chronic Myeloid Leukemias and Myelodysplasia |
|
|
167 | (10) |
|
|
167 | (5) |
|
|
168 | (1) |
|
|
169 | (2) |
|
Philadelphia-negative-chronic myeloid leukemia |
|
|
171 | (1) |
|
Myelodysplastic syndromes |
|
|
172 | (4) |
|
Monosomy 7 syndrome of childhood |
|
|
176 | (1) |
|
|
176 | (1) |
|
Chronic lymphoid Leukemias |
|
|
177 | (14) |
|
|
177 | (1) |
|
Chronic Lymphocytic Leukemia |
|
|
177 | (5) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
Chronic lymphocytic leukemia: mixed cell types |
|
|
181 | (1) |
|
Richter's syndrome (immunoblastic transformation) |
|
|
182 | (1) |
|
|
182 | (1) |
|
|
183 | (2) |
|
Hairy cell leukemia variant |
|
|
185 | (1) |
|
|
185 | (1) |
|
Leukemia--lymphoma syndromes |
|
|
185 | (2) |
|
Splenic lymphoma with villous lymphocytes |
|
|
185 | (1) |
|
Lymphoplasmacytic lymphoma |
|
|
186 | (1) |
|
Follicular lymphoma in leukemia phase |
|
|
186 | (1) |
|
|
186 | (1) |
|
|
187 | (1) |
|
Large granular lymphocytic leukemia (chronic T-cell lymphocytosis) |
|
|
187 | (1) |
|
T-Cell prolymphocytic leukemia |
|
|
187 | (1) |
|
Adult T-cell leukemia--lymphoma |
|
|
188 | (2) |
|
|
190 | (1) |
|
|
191 | (56) |
|
|
191 | (17) |
|
|
191 | (1) |
|
Georgraphic variation, viruses, chromosomes and oncogenes |
|
|
191 | (1) |
|
Clinical features and diagnosis |
|
|
192 | (4) |
|
|
196 | (9) |
|
Classification of lymphoma |
|
|
205 | (1) |
|
The Revised European--American Lymphoma (REAL) and World Health Organization [ WHO] schemes |
|
|
205 | (3) |
|
The World Health Organization classification |
|
|
208 | (1) |
|
B Cell non-Hodgkin lymphoma |
|
|
208 | (7) |
|
Precursor B cell acute lymphoblastic lymphoma/leukemia |
|
|
208 | (1) |
|
Small lymphocytic lymphoma and chronic lymphocytic leukemia |
|
|
208 | (1) |
|
Lymphoplasmacytic lymphoma (immunocytoma) |
|
|
208 | (2) |
|
|
210 | (1) |
|
|
210 | (2) |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
213 | (1) |
|
Diffuse large B cell lymphoma |
|
|
213 | (1) |
|
Plasmacytoma and multiple myeloma |
|
|
214 | (1) |
|
Rare and provisional B cell entities |
|
|
214 | (1) |
|
|
215 | (6) |
|
Precursor T cell acute lymphoblastic lymphoma and/or leukemia |
|
|
215 | (1) |
|
Chronic T cell chronic lymphocytic leukemia |
|
|
215 | (1) |
|
Large granular lymphocytic leukemia |
|
|
215 | (1) |
|
Mycosis fungoides and Sezary syndrome |
|
|
215 | (1) |
|
Peripheral T cell lymphoma, unspecified |
|
|
216 | (2) |
|
T/NK nasal-type (angiocentric) lymphoma |
|
|
218 | (1) |
|
Intestinal- and/or enteropathy-associated T cell lymphoma |
|
|
218 | (2) |
|
Other peripheral T cell lymphomas |
|
|
220 | (1) |
|
Angioimmunoblastic lymphadenopathy |
|
|
220 | (1) |
|
Adult T cell leukemia/lymphoma |
|
|
220 | (1) |
|
Anaplastic large cell lymphoma |
|
|
220 | (1) |
|
Treatment of non-Hodgkin lymphoma |
|
|
221 | (2) |
|
|
222 | (1) |
|
|
222 | (1) |
|
Burkitt's lymphoma and lymphoblastic lymphoma |
|
|
222 | (1) |
|
Histological grading and prognostic markers |
|
|
222 | (1) |
|
Unclassified and reactive lymphoproliferative disorders |
|
|
222 | (1) |
|
True histiocytic lymphomas and other histiocytic proliferations |
|
|
223 | (1) |
|
|
223 | (1) |
|
Hodgkin lymphoma (Hodgkin's disease) |
|
|
223 | (10) |
|
Presentation and evolution |
|
|
223 | (4) |
|
Classification of Hodgkin lymphoma |
|
|
227 | (2) |
|
|
229 | (3) |
|
|
232 | (1) |
|
Myeloma and Related Conditions |
|
|
233 | (7) |
|
|
233 | (5) |
|
|
238 | (1) |
|
|
238 | (2) |
|
|
240 | (1) |
|
|
240 | (2) |
|
Solitary plasmacytoma of bone |
|
|
241 | (1) |
|
|
241 | (1) |
|
Waldenstrom's macroglobulinemia |
|
|
242 | (2) |
|
Other causes of serum M-proteins |
|
|
244 | (3) |
|
Benign monoclonal gammopathy |
|
|
244 | (1) |
|
|
244 | (1) |
|
|
245 | (2) |
|
Non-Leukemic Myeloproliferative Disorders |
|
|
247 | (12) |
|
|
247 | (3) |
|
|
250 | (4) |
|
Essential thrombocythemia |
|
|
254 | (3) |
|
Leukemic transformation of polycythemia vera and myelofibrosis |
|
|
257 | (1) |
|
|
258 | (1) |
|
Stem Cell Transplantation |
|
|
259 | (8) |
|
Steam cell transplantation |
|
|
259 | (2) |
|
Low intensity conditioning (LIC)-transplants |
|
|
261 | (1) |
|
|
261 | (1) |
|
Complications of stem cell transplants |
|
|
261 | (6) |
|
Graft-versus-host disease |
|
|
264 | (3) |
|
Vascular and Platelet Bleeding Disorders |
|
|
267 | (12) |
|
Hemostasis and bleeding disorders |
|
|
267 | (1) |
|
Vascular bleeding disorders |
|
|
268 | (4) |
|
Hereditary hemorrhagic telangiectasia |
|
|
269 | (1) |
|
|
269 | (1) |
|
|
269 | (1) |
|
|
269 | (1) |
|
Purpura associated with abnormal proteins |
|
|
270 | (1) |
|
|
270 | (1) |
|
Pupura associated with infection |
|
|
270 | (2) |
|
Platelet bleeding disorders |
|
|
272 | (7) |
|
|
272 | (4) |
|
Disorders of platelet function |
|
|
276 | (3) |
|
|
279 | (18) |
|
|
279 | (1) |
|
Hereditary coagulation disorders |
|
|
279 | (8) |
|
|
279 | (5) |
|
Carrier detection and diagnosis |
|
|
284 | (1) |
|
|
284 | (3) |
|
Other hereditary coagulation disorders |
|
|
287 | (1) |
|
Acquired coagulation disorders |
|
|
287 | (3) |
|
|
287 | (1) |
|
Overdosage with anticoagulants |
|
|
287 | (1) |
|
Disseminated intravascular coagulation |
|
|
288 | (1) |
|
Acquired coagulation factor inhibitor |
|
|
288 | (2) |
|
|
290 | (2) |
|
Inherited thrombotic disorders |
|
|
290 | (2) |
|
Acquired thrombotic risk factors |
|
|
292 | (1) |
|
Diagnosis of venous thrombosis |
|
|
292 | (2) |
|
|
294 | (3) |
|
|
294 | (1) |
|
|
294 | (1) |
|
|
294 | (2) |
|
|
296 | (1) |
|
Bone Marrow in Non-Hemopoietic Diseases |
|
|
297 | (16) |
|
|
297 | (3) |
|
|
300 | (1) |
|
|
300 | (2) |
|
|
300 | (2) |
|
|
302 | (1) |
|
|
302 | (1) |
|
Kala-azar (visceral leishmaniasis) |
|
|
302 | (1) |
|
|
303 | (1) |
|
Lysosomal storage diseases |
|
|
303 | (4) |
|
|
303 | (3) |
|
|
306 | (1) |
|
Sea-blue histiocyte syndrome |
|
|
306 | (1) |
|
|
307 | (1) |
|
|
307 | (1) |
|
Osteopetrosis (Albers--Schonberg or marble bone disease) |
|
|
307 | (1) |
|
|
308 | (2) |
|
Renal asteodystrophy and osteomalacia |
|
|
310 | (1) |
|
Paget's disease of bone (osteitis deformans) |
|
|
310 | (1) |
|
|
311 | (1) |
|
Systemic lupus erythematosus |
|
|
312 | (1) |
|
Magnetic resonance imaging of bone marrow |
|
|
312 | (1) |
|
Parasitic Infections Diagnosed in Blood |
|
|
313 | (8) |
|
|
313 | (4) |
|
Effect of malaria on various organs |
|
|
315 | (1) |
|
Comparative methods for malaria diagnosis |
|
|
316 | (1) |
|
|
317 | (1) |
|
|
317 | (1) |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
320 | (1) |
|
|
321 | (14) |
|
|
321 | (5) |
|
|
321 | (1) |
|
|
322 | (1) |
|
|
322 | (1) |
|
|
322 | (1) |
|
Blood grouping and cross-matching |
|
|
323 | (1) |
|
|
324 | (1) |
|
Clinical blood transfusion |
|
|
324 | (2) |
|
Complications of blood transfusions |
|
|
326 | (2) |
|
|
326 | (1) |
|
|
326 | (2) |
|
|
328 | (1) |
|
Transfusion-related acute lung injury |
|
|
328 | (1) |
|
Graft-versus-host disease |
|
|
328 | (1) |
|
|
328 | (2) |
|
|
329 | (1) |
|
|
329 | (1) |
|
|
329 | (1) |
|
Human leucocyte antigen system |
|
|
330 | (2) |
|
Human leucocyte antigen nomenclature |
|
|
330 | (2) |
|
Typing of human leucocyte antigens |
|
|
332 | (1) |
|
Other human leucocyte antigens |
|
|
332 | (3) |
Appendix 1 |
|
335 | (4) |
Appendix 2 |
|
339 | (1) |
Index |
|
340 | |